Cite
HARVARD Citation
Trappe, R. et al. (n.d.). International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20‐Positive B Cell PTLD: Clues From the PTLD‐1 Trial. American journal of transplantation. 15 (4), pp. 1091-1100. [Online].